Magenta Therapeutics
Utility Patents

Last updated:

List of all Magenta Therapeutics patents 10 in total

Status Patent
Grant
Utility: Dosing regimens for the mobilization of hematopoietic stem and progenitor cells External link
Filling date: 6 Sep 2025 Issue date: 1 Mar 2022
Grant
Utility: Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use External link
Filling date: 6 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: Aryl hydrocarbon receptor antagonists and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 16 Feb 2021
Grant
Utility: Compositions and methods for the depletion of CD117+ cells External link
Filling date: 6 Sep 2025 Issue date: 26 Jan 2021
Grant
Utility: Compositions and methods for the depletion of CD117+ cells External link
Filling date: 6 Sep 2025 Issue date: 5 Jan 2021
Grant
Utility: Modified antibodies and related compounds, compositions, and methods of use External link
Filling date: 6 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Methods for the depletion of cells External link
Filling date: 6 Sep 2025 Issue date: 21 Apr 2020
Grant
Utility: Compositions and methods for the depletion of CD137+ cells External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2020
Grant
Utility: Aryl hydrocarbon receptor antagonists and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2019
Grant
Utility: Compositions and methods for the depletion of CD137+ cells External link
Filling date: 6 Sep 2025 Issue date: 8 Oct 2019

Showing 1 to 10 of 10 patents.